75 tracked 13F filers disclose a position in LYEL as of the latest SEC 13F filings, a combined $172.6M in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| # | Fund | Position value | Shares | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | ARCH Venture Management, LLC | $45.5M | 3.2M | —Held | Q2 2026 | |
| 2 | Foresite Capital Management IV, LLC | $16.1M | 800K | —Held | Q1 2026 | |
| 3 | Orland Properties Ltd | $10.6M | 755K | —Held | Q2 2026 | |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | $14.4M | 718K | →First observed position No prior filed position | Q1 2026 | |
| 5 | Almitas Capital LLC | $8.2M | 581K | ▲+0.6% Added · +4K sh | Q2 2026 | |
| 6 | Foresite Capital Management V, LLC | $9.6M | 477K | —Held | Q1 2026 | |
| 7 | MILLENNIUM MANAGEMENT LLC | $9.2M | 459K | ▲+682% Added · +400K sh | Q1 2026 | |
| 8 | CITADEL ADVISORS LLC | $7.7M | 381K | ▲+17% Added · +57K sh | Q1 2026 | |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | $4.4M | 311K | ▲+86% Added · +144K sh | Q2 2026 | |
| 10 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | $6.2M | 310K | ▲+105% Added · +159K sh | Q1 2026 | |
| 11 | Alphabet Inc. | $4.1M | 293K | —Held | Q2 2026 | |
| 12 | BlackRock, Inc. | $3.8M | 192K | ▲+5.5% Added · +10K sh | Q1 2026 | |
| 13 | STATE STREET CORP | $2.6M | 185K | ▲+156% Added · +113K sh | Q2 2026 | |
| 14 | HSG Holding Ltd | $2.1M | 152K | —Held | Q2 2026 | |
| 15 | MARSHALL WACE, LLP | $3.0M | 149K | ▲+103% Added · +75K sh | Q1 2026 | |
| 16 | RENAISSANCE TECHNOLOGIES LLC | $2.3M | 116K | ▲+195% Added · +77K sh | Q1 2026 | |
| 17 | GOLDMAN SACHS GROUP INC | $2.3M | 114K | ▲+18% Added · +18K sh | Q1 2026 | |
| 18 | Velan Capital Investment Management LP | $1.5M | 105K | ▲+2.9% Added · +3K sh | Q2 2026 | |
| 19 | MIC Capital Management UK LLP | $1.2M | 87K | —Held | Q2 2026 | |
| 20 | VANGUARD FIDUCIARY TRUST CO | $1.7M | 87K | →First observed position No prior filed position | Q1 2026 | |
| 21 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1.7M | 86K | ▲+0.6% Added · +548 sh | Q1 2026 | |
| 22 | Opaleye Management Inc. | $1.6M | 79K | ▲New +79K sh | Q1 2026 | |
| 23 | JANE STREET GROUP, LLC | $1.3M | 64K | ▲+415% Added · +51K sh | Q1 2026 | |
| 24 | MORGAN STANLEY | $1.1M | 56K | ▲+31% Added · +13K sh | Q1 2026 | |
| 25 | Qube Research & Technologies Ltd | $1.1M | 55K | ▲+509% Added · +46K sh | Q1 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
Last quarter, 12 funds opened a new position in LYEL and 10 added to an existing one, while 5 reduced and 0 exited entirely — based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).
| Company | Co-held by | Combined value |
|---|---|---|
| ELI LILLY & COLLY | 30 funds | $18.4B |
| ALPHABET INC-CL AGOOGL | 29 funds | $38.0B |
| META PLATFORMS INC-CLASS AMETA | 29 funds | $28.7B |
| COSTCO WHOLESALE CORPCOST | 29 funds | $7.6B |
| TERADYNE INCTER | 29 funds | $2.9B |
| BRISTOL-MYERS SQUIBB COBMY | 29 funds | $2.7B |
| CARDINAL HEALTH INCCAH | 29 funds | $1.8B |
| MCKESSON CORPMCK | 29 funds | $1.7B |
| CADENCE DESIGN SYS INCCDNS | 29 funds | $1.7B |
| AUTOMATIC DATA PROCESSINGADP | 29 funds | $1.4B |
| MONSTER BEVERAGE CORPMNST | 29 funds | $1.0B |
| NVIDIA CORPNVDA | 28 funds | $96.8B |
Ranked by how many of LYEL's institutional holders also hold each name, a cross-fund conviction signal.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Aug 21, 2026 | Lee Gary K. | Chief Scientific Officer | Sell (S) | 1K | $23K |
| Aug 21, 2026 | Hill Stephen J. | Chief Operating Officer | Sell (S) | 989 | $15K |
| Aug 21, 2026 | Seely Lynn | President and CEO, Director | Sell (S) | 10K | $149K |
| Aug 10, 2026 | Lee Gary K. | Chief Scientific Officer | Sell (S) | 131 | $2K |
| Aug 10, 2026 | Bulis Veronica Sanchez | VP, Corporate Controller | Sell (S) | 621 | $9K |
| Aug 10, 2026 | Hill Stephen J. | Chief Operating Officer | Sell (S) | 89 | $1K |
| Aug 10, 2026 | Seely Lynn | President and CEO, Director | Sell (S) | 390 | $6K |
| Jul 17, 2026 | Innovative Cellular Therapeutics Holdings Ltd | 10% Owner | Sell (S) | 10 | $137 |
| Jul 16, 2026 | Innovative Cellular Therapeutics Holdings Ltd | 10% Owner | Sell (S) | 10 | $137 |
| Jun 10, 2026 | Shook David | Chief Medical Officer | Sell (S) | 2K | $25K |
| May 11, 2026 | Seely Lynn | President and CEO, Director | Sell (S) | 388 | $7K |
| May 11, 2026 | Lee Gary K. | Chief Scientific Officer | Sell (S) | 130 | $2K |
| Class | 13F holders | Value held |
|---|---|---|
| LYELthis pageStock | 75 funds | $172.6M |
| 55083R104COM | 1 funds | $9.7M |
Same issuer, multiple share classes. The consensus leaderboards count this company once across all classes; this is the per-class detail.
Connected entities for LYEL
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/LYEL/capital-change-brief"
Use Arkolith's capital_change_brief for LYEL. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for LYEL. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.